NEUROPACE, INC. Debt Securities, Unrealized Gain (Loss)
NEUROPACE, INC. (NPCE) reported Debt Securities, Unrealized Gain (Loss) of -$100.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesUnrealizedGainLoss · last filed 2026-08-11
- NEUROPACE, INC. debt securities, unrealized gain (loss) for the quarter ending 2026-06-30 was -$100.00K, a 200.00% decline year-over-year.
- NEUROPACE, INC. debt securities, unrealized gain (loss) for the quarter ending 2026-03-31 was -$200.00K.
- NEUROPACE, INC. debt securities, unrealized gain (loss) for the quarter ending 2025-12-31 was $200.00K.
- NEUROPACE, INC. debt securities, unrealized gain (loss) for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- NEUROPACE, INC. debt securities, unrealized gain (loss) for fiscal 2025 was $100.00K, a 50.00% decline from fiscal 2024.
- NEUROPACE, INC. debt securities, unrealized gain (loss) for fiscal 2024 was $200.00K, a 80.00% decline from fiscal 2023.
- NEUROPACE, INC. debt securities, unrealized gain (loss) for fiscal 2023 was $1.00M.
| Period end | Debt Securities, Unrealized Gain (Loss) 3 month | Debt Securities, Unrealized Gain (Loss) 6 month | Debt Securities, Unrealized Gain (Loss) 9 month | Debt Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$100.00K 10-Q · filed 2026-08-11 | -$200.00K 10-Q · filed 2026-08-11 | -$100.00K derived: sum of 3 quarters · filed 2026-08-11 | -$100.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$200.00K 10-Q · filed 2026-05-12 | $0.00 derived: sum of 2 quarters · filed 2026-05-12 | $0.00 derived: sum of 3 quarters · filed 2026-05-12 | $100.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $200.00K derived: sum of 2 quarters · filed 2026-03-03 | $300.00K derived: sum of 3 quarters · filed 2026-08-11 | $100.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $100.00K derived: sum of 2 quarters · filed 2026-08-11 | -$100.00K 10-Q · filed 2025-11-04 | -$100.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $100.00K 10-Q · filed 2026-08-11 | -$100.00K 10-Q · filed 2026-08-11 | -$100.00K derived: sum of 3 quarters · filed 2026-08-11 | $100.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$100.00K 10-Q · filed 2026-05-12 | -$200.00K derived: sum of 2 quarters · filed 2026-05-12 | $0.00 derived: sum of 3 quarters · filed 2026-05-12 | $100.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $100.00K derived: sum of 2 quarters · filed 2026-03-03 | $200.00K derived: sum of 3 quarters · filed 2026-03-03 | $200.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | $200.00K 10-Q · filed 2025-11-04 | $300.00K derived: sum of 2 quarters · filed 2025-11-04 | $300.00K 10-Q · filed 2025-11-04 | $700.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $100.00K 10-Q · filed 2025-08-12 | $100.00K 10-Q · filed 2025-08-12 | $500.00K derived: sum of 3 quarters · filed 2025-08-12 | $600.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $100.00K 10-Q · filed 2025-05-13 | $400.00K derived: sum of 2 quarters · filed 2025-05-13 | $500.00K derived: sum of 3 quarters · filed 2025-05-13 | $600.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $400.00K derived: sum of 2 quarters · filed 2025-03-04 | $500.00K derived: sum of 3 quarters · filed 2025-03-04 | $1.00M 10-K · filed 2025-03-04 |
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-12 | $200.00K derived: sum of 2 quarters · filed 2024-11-12 | $700.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $100.00K 10-Q · filed 2024-08-13 | $600.00K 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $400.00K 10-Q · filed 2024-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |